American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

American Vanguard Corporation ($0.10 Par Value)

Wells Fargo analyst Benjamin Burnett maintained a Hold rating on Avadel Pharmaceuticals today and set a price target of $22.50. According to TipRan...

Avadel Pharmaceuticals (AVDL) Gets a Hold from Wells Fargo

Analysts fell to the sidelines weighing in on Avadel Pharmaceuticals (AVDL – Research Report) and Oncolytics Biotech (ONCY – Research Report) with ...

Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Oncolytics Biotech (ONCY)

Avadel Pharmaceuticals ( ($AVDL) ) has issued an announcement. On November 18, 2025, Avadel Pharmaceuticals and Alkermes plc amended their original...

Avadel Pharmaceuticals Amends Agreement with Alkermes

Avada Group Limited ( ($AU:AVD) ) just unveiled an update. Avada Group Limited announced the results of its 2025 Annual General Meeting, highlighti...

Avada Group Limited Reports Strong Shareholder Support at 2025 AGM

Avada Group Limited ( ($AU:AVD) ) just unveiled an update. AVADA Group Limited’s CEO, Donald Montgomery, highlighted the company’s transformation a...

AVADA Group Limited Strengthens Market Position Amidst Challenges

Avada Group Limited ( ($AU:AVD) ) has issued an announcement. AVADA Group Limited’s 2025 Annual General Meeting highlighted a year of consolidation...

AVADA Group Limited Navigates Transformation Amidst Market Challenges

American Vanguard ( ($AVD) ) has issued an update. American Vanguard reported a substantial improvement in its financial performance for the third ...

American Vanguard Reports Q3 2025 Financial Improvement

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Avadel Pharmaceuticals (AVDL – Research Report) and Sarepta Thera...

Market Cap	$149.83M	P/E Ratio	NaN
52W High	$6.33	52W Low	$3.28
Div Yield	N/A	Payout Ratio	-10.4%
EPS Growth 3Y	-110.0%	52W Position	34.1%
Overall Score	52	Value Score	60
Quality Score	--	Technical Score	45

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	-9.1%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AVD	$4.32	-0.46%	263.81K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AVD	$4.32	-0.5%	263.81K
3
4
5
6

AVD

AVD

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get American Vanguard Corporation ($0.10 Par Value) Data in Excel

Get American Vanguard Corporation ($0.10 Par Value) Data in Excel